ABOUT US

At Medison, we are Always Ahead - creating a new global partnership model to deliver breakthrough therapies to patients who need them most.

Even today, the majority of the world’s population still faces significant barriers to accessing life-changing treatments, especially for the treatment of rare and severe diseases. Despite scientific progress, access remains uneven, with many regions underserved by traditional commercialization approaches.

This vast, underserved region, covering Most of the World’s population, is what we call the 4th Territory. It represents the second-largest global healthcare opportunity and includes all markets beyond the U.S., Western Europe, and Japan.

As the creator of a first-of-its-kind, unified global commercialization platform, Medison accelerates access to breakthrough therapies in the 4th Territory, directly impacting more than one billion lives across Latin America, Eastern and Central Europe, Asia-Pacific, Canada, the Middle East, and beyond.

Our end-to-end model combines global infrastructure with local expertise, spanning commercial, medical, regulatory, and operational capabilities tailored to each market. This allows biotechs to scale globally while retaining strategic control, simplifying international commercialization through one long-term strategic partner and making a real impact where it matters most.

Our mission is clear: to close critical access gaps and bring our partners breakthrough innovation to patients, no matter where they live. Every therapy we help bring to market, is a step toward a healthier, more equitable world.

A letter from our Founder & Executive Chairman, Meir Jakobsohn

Imagine this: Two children, born on the same day, are diagnosed with the same severe and rare illness. Despite the similarity, they will face very different odds of surviving simply because of where they live. Medison was created out of a patient-centric mission to save lives by bridging this life-threatening gap in international markets.

Having grown up in a family rooted in pharmaceuticals, I’ve seen this industry evolve up close, from traditional distribution models to an era of transformative science. Along the way, I saw an urgent need: to ensure that patients, no matter where they live, can benefit from medical innovation. This led me to found Medison in 1996.

Since then, Medison has come a long way. Today, we are a single global partner for biotech commercialization, accelerating the launch of breakthrough therapies in markets beyond the U.S., Western Europe, and Japan, what we refer to as the 4th territory. We now span across five continents, expanding global access while ensuring patients receive the treatments they need.

At Medison, we embrace the spirit of ‘Always Ahead’, both as a mindset and a way of working. We lead with purpose, move with agility, and continuously innovate to bring breakthrough therapies to patients across the 4th territory.

Our teams are fiercely determined to bridge the gap in healthcare access. We are driven every day to move forward as one, so that no patient is left behind.

Sincerely,

Meir Jakobsohn, Founder and Executive Chairman

We believe that all patients, wherever they are in the world, have the right to get access to the best available novel treatments, and we are here to make this happen

Our Values

Always Ahead

As a company that is the creator and leader of the global platform, one of the mottos we live by is “building while running.” We continuously adapt and evolve, staying ahead for the benefit of patients in need. Our “can do” approach and creative thinking drive us forward, enabling us to stay ahead of the curve and drive positive change.

Grow As One

Our mission is to accelerate access to life-saving treatments, and the ability to do so lies in the power of collaboration across functions and geographies, teamwork and knowledge sharing on all levels. We recognize that we can be successful only as ONE Medison, which is one of the fundamental principles of our business model.

We Care

At Medison, we act with a purpose. We are deeply committed and go above and beyond in providing innovative therapies, aiming to improve the lives of patients suffering from rare and severe diseases in international markets. We also extend this care to each other, fostering an environment of respect and camaraderie that contributes to a positive workplace atmosphere.